aminoglycosid clearanc in patient with cystic fibrosi letter we have been util a patient individu pharmacokinet profil to plan and monitor aminoglycosid therapi and we have often note what appear to be an extrem rapid elimin rate of gentamicin in our patient with cystic fibrosi the patient with cystic fibrosi had significantli greater renal and total clearanc than those without cystic fibrosi if thi observ could be extend to other drug such as the aminoglycosid which are not normal subject to renal secret it would prove intrigu evid for a possibl primari renal defect in these patient